Overview

Studying the Effects of Sibutramine on Eating Behavior

Status:
Terminated
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Obesity is a major public health concern, and the search for useful pharmacologic interventions is ongoing. This study aims to develop a comprehensive series of assessments to directly assess eating behavior, cognitive functioning, and psychological functioning under sibutramine and placebo conditions.
Phase:
Phase 4
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
AstraZeneca
Treatments:
Sibutramine